ClinicalTrials.gov
ClinicalTrials.gov Menu

Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons (HAART-IPT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00463086
Recruitment Status : Completed
First Posted : April 20, 2007
Last Update Posted : July 17, 2012
Sponsor:
Collaborators:
Medecins Sans Frontieres, Netherlands
Imperial College London
Johns Hopkins University
London School of Hygiene and Tropical Medicine
Information provided by (Responsible Party):
Prof Gary Maartens, University of Cape Town

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 2011
  Actual Study Completion Date : November 2011